Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 2/20 | 0.67 |
| ▸ | GABRD | O14764 | 2/20 | 0.67 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.67 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.67 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.67 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.67 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.67 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.67 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.67 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.67 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.67 |
| ▸ | GABRE | P78334 | 2/20 | 0.67 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.67 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.67 |
| ▸ | GABRG3 | Q99928 | 2/20 | 0.67 |
| ▸ | GABRQ | Q9UN88 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 5/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL538579 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1881592 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL31158246 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1876354 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1882607 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL244824 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1885384 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1875146 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1882596 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1880221 | 1.00 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200270597-A1 | Hybrid Polyketide Synthases | UNITED STATES DEPARTMENT OF ENERGY | 2020-08-27 | — | — | US | claimed |
| CN-120059454-A | Antibacterial, antistatic, halogen-free and flame-retardant reinforced polyamide composition and preparation method thereof | 中国商用飞机有限责任公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119490745-A | Flame retardant polyamide composition and method for preparing same | 中国商用飞机有限责任公司 | 2025-02-21 | — | — | CN | disclosed |
| CN-117717620-A | Mitochondrial targeting polypeptide-drug conjugate and preparation method and application thereof | 中国人民解放军海军军医大学 | 2024-03-19 | — | — | CN | disclosed |
| US-20230331685-A1 | HERBICIDAL COMPOUNDS AND METHODS OF USE THEREOF | AG PLENUS LTD (IL) | 2023-10-19 | — | — | US | disclosed |
| US-20230331685-A1 | HERBICIDAL COMPOUNDS AND METHODS OF USE THEREOF | AG PLENUS LTD (IL) | 2023-10-19 | — | — | US | disclosed |
| EP-3700667-A1 | POROUS FIBROUS SEPARATION MATERIAL | Nonwovens Innovation and Research Institute (GB) | 2020-09-02 | — | — | EP | disclosed |
| US-9844621-B2 | Separation material | GAMBRO LUNDIA AB (SE) | 2017-12-19 | — | — | US | disclosed |
| CN-104053462-B | SEPARATION MATERIAL COMPRISING SACCHARIDE LIGANDS | 甘布罗伦迪亚股份公司 | 2017-04-26 | — | — | CN | disclosed |
| US-9259710-B2 | Separation material comprising saccharide ligands | Gambro Lunia AB (SE) | 2016-02-16 | — | — | US | disclosed |
| WO-2013020964-A1 | SEPARATION MATERIAL COMPRISING SACCHARIDE LIGANDS | GAMBRO LUNDIA AB (SE) | 2013-02-14 | — | — | WO | disclosed |
| EP-2556848-A1 | Separation material comprising saccharide ligands | Gambro Lundia AB (SE) | 2013-02-13 | — | — | EP | disclosed |
| EP-2556849-A1 | Separation material | Gambro Lundia AB (SE) | 2013-02-13 | — | — | EP | disclosed |
| US-20110105417-A1 | Drug Conjugates | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2011-05-05 | — | — | US | disclosed |
| WO-2009158633-A1 | DRUG CONJUGATES | CURATORS OF THE UNIVERSITY OF MISSOURI ON BEHALF OF THE UNIVERSITY OF MISSOURI-KANSAS CITY (US) | 2009-12-30 | — | — | WO | disclosed |
| CN-100486589-C | Slow release antibiotics preparation of bioactive substance | HELLICH GUESA KG (DE) | 2009-05-13 | — | — | CN | disclosed |
| EP-1429815-A1 | MIXTURE FOR USE AS A PROTECTIVE DRESSING | MBS Multination Business Services (M.E.) Ltd. (CY) | 2004-06-23 | — | — | EP | disclosed |
| WO-2003026710-A1 | MIXTURE FOR USE AS A PROTECTIVE DRESSING | MBS MULTINATION BUSINESS SERVICES (M.E.) LTD. (CY) | 2003-04-03 | — | — | WO | disclosed |
| WO-2002100338-A2 | COMPOUND AND COMPOSITION FOR DELIVERING ACTIVE AGENTS | EMISPHERE TECHNOLOGIES, INC. (US) | 2002-12-19 | — | — | WO | disclosed |
| CN-1376469-A | Slow release antibiotics preparation of bioactive substance | HELLICH GUESA KG (DE) | 2002-10-30 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110105417-A1 | Drug Conjugates | ABCB1, SLCO2B1, ABCG2 | GABRP 691/4885GABRD 761/4885GABRA1 924/4885 |
| US-20230331685-A1 | HERBICIDAL COMPOUNDS AND METHODS OF USE THEREOF | DDT, HDHD5, HPD | GABRP 2485/4885GABRD 1467/4885GABRA1 2547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.